Trevi Therapeutics, Inc. (NASDAQ:TRVI) is held by 182 institutional investors per 13F filings through December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| NEA Management Company, LLC | 31 Mar, 2026 | 13,222,228 | 0 | 0.00% | $157,741,180.00 |
| NEA Management Company, LLC | 31 Mar, 2026 | 13,222,228 | 0 | 0.00% | $165,542,295.00 |
| Frazier Life Sciences Management, L.P. | 31 Mar, 2026 | 10,259,409 | 0 | 0.00% | $128,447,801.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 10,240,186 | 114,003 | 1.13% | $122,165,419.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 10,126,183 | 225,130 | 2.27% | $126,779,812.00 |
| Frazier Life Sciences Management, L.P. | 31 Mar, 2026 | 9,939,547 | -319,862 | -3.12% | $118,578,796.00 |
| FMR LLC | 31 Mar, 2026 | 8,038,061 | 1,538,052 | 23.66% | $95,894,063.00 |
| FMR LLC | 31 Mar, 2026 | 6,500,009 | 3,200,118 | 96.98% | $81,380,117.00 |
| VANGUARD GROUP INC | 31 Mar, 2026 | 6,434,655 | 607,669 | 10.43% | $80,561,880.00 |
| WELLINGTON MANAGEMENT GROUP LLP | 31 Mar, 2026 | 5,189,088 | 1,785,098 | 52.44% | $61,905,820.00 |
| Vivo Capital, LLC | 31 Mar, 2026 | 5,094,668 | 0 | 0.00% | $63,785,243.00 |
| Vivo Capital, LLC | 31 Mar, 2026 | 5,094,668 | 0 | 0.00% | $60,779,389.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 4,978,567 | 4,978,567 | 0.00% | $59,394,304.00 |
| MARSHALL WACE, LLP | 31 Mar, 2026 | 4,580,548 | -261,203 | -5.39% | $57,348,462.00 |
| MARSHALL WACE, LLP | 31 Mar, 2026 | 3,966,019 | -614,529 | -13.42% | $47,314,607.00 |
| Rubric Capital Management LP | 31 Mar, 2026 | 3,766,749 | -4,765,111 | -55.85% | $47,159,697.00 |
| Rubric Capital Management LP | 31 Mar, 2026 | 3,712,373 | -54,376 | -1.44% | $44,288,610.00 |
| WELLINGTON MANAGEMENT GROUP LLP | 31 Mar, 2026 | 3,403,990 | 150,102 | 4.61% | $42,617,956.00 |
| MPM BioImpact LLC | 31 Mar, 2026 | 3,298,430 | 11,343 | 0.35% | $39,350,270.00 |
| MPM BioImpact LLC | 31 Mar, 2026 | 3,287,087 | -119,868 | -3.52% | $41,154,329.00 |